Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
883.2 USD | -0.84% | -1.52% | +0.56% |
Apr. 26 | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
Apr. 26 | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Bullish |
Resistance | 917.56 | 993.35 | 982.82 |
Spread/Res. | -3.74% | -11.09% | -10.14% |
Spread/Supp. | +0.81% | +0.81% | +8.12% |
Support | 876.12 | 876.12 | 816.90 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.